Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5–11 years: Results from an active pharmacovigilance study in central Italy
Giancarlo Ripabelli, Michela Lucia Sammarco, Antonio D’Amico, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 10

Showing 10 citing articles:

Vaccine conspiracy association with higher COVID-19 vaccination side effects and negative attitude towards booster COVID-19, influenza and monkeypox vaccines: A pilot study in Saudi Universities
Samiyah Alshehri, Malik Sallam
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 9
Safety of an inactivated COVID-19 vaccine (CoronaVac) in children aged 7-14 years in Taizhou, China
Dongsheng Zhang, Xue-ping Bao, Jingjing Zhu, et al.
Diagnostic Microbiology and Infectious Disease (2024) Vol. 109, Iss. 2, pp. 116253-116253
Open Access | Times Cited: 1
Unraveling the association between vaccine attitude, vaccine conspiracies and self-reported side effects following COVID-19 vaccination among nurses and physicians in Jordan
Malik Sallam, Hiba Abbasi, Rawan J. Obeidat, et al.
Vaccine X (2023) Vol. 15, pp. 100405-100405
Open Access | Times Cited: 3
Evaluation of the effects of MERCK, MODERNA, PFIZER/BioNTech, and JANSSEN COVID-19 vaccines on vaccinated people: A metadata analysis
Nadia Al‐Rousan, Hazem Al‐Najjar
Informatics in Medicine Unlocked (2024) Vol. 49, pp. 101564-101564
Open Access
Safety and antibody response of the BNT162b2 SARS-CoV-2 vaccine in children aged 5–11 years with underlying diseases: A prospective observational study
Takanori Funaki, Masaki Yamada, Kozue Miyake, et al.
Journal of Infection and Chemotherapy (2024) Vol. 30, Iss. 8, pp. 773-779
Closed Access
The descriptive epidemiology of adverse events following two doses of mRNA COVID-19 vaccination in Curaçao, the Caribbean
Jonathan Lambo, Sirving Keli, Shaheen Khan Kaplan, et al.
Infectious Diseases (2024), pp. 1-13
Closed Access
Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5–11 years: Author’s reply to correspondence
Giancarlo Ripabelli, Angelo Salzo, Manuela Tamburro
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access
Effectiveness of the BNT162b2 vaccine in preventing morbidity and mortality associated with COVID-19 in children aged 5 to 11 years: A systematic review and meta-analysis
Sumayyah Ebrahim, Ntombifuthi Blose, Natasha R Gloeck, et al.
PLOS Global Public Health (2023) Vol. 3, Iss. 12, pp. e0002676-e0002676
Open Access
Pfizer-BioNTech COVID-19 vaccination in children: no serious AEs

Reactions Weekly (2022) Vol. 1932, Iss. 1, pp. 12-12
Closed Access
Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 7
Open Access
Page 1

Scroll to top